< Back to Biozen Biologics LC Column

Product Finder

Select your ideal Biozen LC phase based on type of separation or workflow

smooth-scroll-horizontal-tabs
4
Aggregate Analysis

Biozen dSEC-2

Biozen dSEC-7

Biozen SEC-3

#F2F5F9
Fragment/Sub Unit Analysis (SEC)

Biozen dSEC-2

Biozen SEC-3

#F2F5F9
Fragment/Sub Unit Analysis (RP)

Biozen WidePore C4

Biozen Intact XB-C8

#F2F5F9
Native MS/Intact Mass (SEC)

Biozen dSEC-2

Biozen SEC-3

#F2F5F9
Native MS/Intact Mass (IEX)
Biozen WCX
#F2F5F9
Native MS/Intact Mass (RP)

Biozen WidePore C4

Biozen Intact XB-C8

#F2F5F9
Charge Variant Analysis
Biozen WCX
#F2F5F9
Peptide Quantitation

Biozen Peptide PS-C18

Biozen Peptide XB-C18

#F2F5F9
Peptide Mapping

Biozen Peptide PS-C18

Biozen Peptide XB-C18

#F2F5F9
Average Drug Antibody Ratio (DAR-SEC)

Biozen dSEC-2

Biozen SEC-3

#F2F5F9
Average Drug Antibody Ratio (DAR-RP)

Biozen WidePore C4

Biozen Intact XB-C8

#F2F5F9
Glycan Mapping
Biozen Glycan
#F2F5F9
Oligonucleotide Characterization
Biozen Oligo
#F2F5F9
Proteomics
Biozen Nano
#F2F5F9
4
Reversed Phase (Peptide)

Biozen Peptide PS-C18

Biozen Peptide XB-C18

#F2F5F9
Reversed Phase (Protein)

Biozen WidePore C4

Biozen Intact XB-C8

#F2F5F9
Reversed Phase (Oligos)
Biozen Oligo
#F2F5F9
Size Exclusion

Biozen dSEC-7

Biozen dSEC-2

Biozen SEC-3

#F2F5F9
Ion-Exchange (IEX)
Biozen WCX
#F2F5F9
HILIC
Biozen Glycan
#F2F5F9